The interaction of stroma-secreted CCL2 with CCR2+ MDSCs is essential for the complex crosstalk between cancer cells, stromal cells, and MDSCs; thus, it promises to constitute an attractive target for OSCC treatment. This evidence concerns the gene CCR2 and cancer.